Peregrine Asset Advisers’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $886K | Sell |
|
|||||
|
2025
Q2 | $913K | Sell |
|
|||||
|
2025
Q1 | $1.21M | Sell |
|
|||||
|
2024
Q4 | $1.17M | Sell |
|
|||||
|
2024
Q3 | $1.21M | Buy |
|
|||||
|
2024
Q2 | $954K | Buy |
|
|||||
|
2024
Q1 | $849K | Hold |
|
|||||
|
2023
Q4 | $803K | Hold |
|
|||||
|
2023
Q3 | $909K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $4.27M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $4.26M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $4.24M | Sell |
|
|||||
|
2017
Q2 | $4.51M | Buy |
|